trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

The HPV vaccine reduces transmission of HPV infection in populations.

the verdict
INSUFFICIENT LEANING
Recorded sources
5 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that the HPV vaccine reduces transmission of HPV infection in populations?

Unclear. Several sources indicate HPV vaccination lowers HPV infection or related outcomes in specific groups: CDC reports large declines in infection among vaccinated US teen girls and young women, a trial reports reduced persistent infection in men, and other records describe prevention of HPV-16/18 infection in women and reduced transmission of genital warts. None of the placed items directly measures reduced HPV transmission across a whole population, so the evidence covers only parts of the claim.

Verdict: PARTIAL LEAN · 5 sources for, 0 against · Last checked

The private library was unavailable for some searches in this check. Missing library results are not evidence against the claim.

Evidence for · 5
2001
Get citation
A Double-blind, Placebo-controlled, Randomised Study of the Efficacy of an HPV-16/18 VLP Vaccine in the Prevention of HPV-16 and/or HPV-18 Cervical Infection in Healthy Adolescent and Young Adult Women in North America and Brazil.. (2001). clinicaltrials.gov. https://clinicaltrials.gov/study/NCT00689741

See more details
More for · 4
Get citation
Impact of the HPV Vaccine | HPV | CDC. (n.d.). cdc.gov. https://www.cdc.gov/hpv/vaccination-impact/index.html

2011
Get citation
Male circumcision for prevention of oncogenic HPV infection. (2011). doi.org. https://doi.org/10.1016/s0140-6736(11)61162-8

2017
Get citation
HPV Vaccination and the Controversy and Attitudes of Male and Female College Students. (2017). doi.org. https://doi.org/10.21767/1791-809x.1000493

2022
Get citation
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Efficacy, Immunogenicity, and Safety of V503, a 9-Valent Human Papillomavirus (HPV) Vaccine, in Chinese Males 20 to 45 Years of Age. (2022). clinicaltrials.gov. https://clinicaltrials.gov/study/NCT05285826

Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work